|
|
 |
|
Viewing report
|
|
 |
 |
New Drug Development: Design, Methodology, and Analysis
John Wiley and Sons Ltd, Sep 2007, Pages: 270
This book acquaints students and practitioners in the related fields of pharmaceutical sciences, clinical trials, and evidence-based medicine with the necessary study design concepts and statistical practices to allow them to understand how drug developers plan and evaluate their drug development. Two goals of the book are to make the material accessible to readers with minimal background in research and to be straightforward enough for self-taught purposes. By bringing the topic from the early discovery phase to clinical trials and medical practice, the book provides an indispensable overview of an otherwise confusing and fragmented set of topics. The author’s experience as a respected scientist, teacher of statistics, and one who has worked in the clinical trials arena makes him well suited to write such a treatise.
Authors Bio: J. RICK TURNER (D. P. University of Birmingham, UK) is Associate Professor of Clinical Research at Campbell University School of Pharmacy (Morrisville, NC). With more than a dozen awards and honors to his name, Dr. Turner has extensive teaching, research, and pharmaceutical credentials. He is the author of seven books and more than 100 journal articles and published abstracts. His specialty areas include cardiovascular behavioral medicine and clinical submissions. In 2005, he was awarded the recipient of a Commit to Product Development Award at GlaxoSmithKline.
Product samples
New Drug Development - Chapter One
Customers who bought this item also bought
New Drug Development: Design, Methodology, and Analysis
Patents in the Postgenomic Era: Proprietary Drug Targets and Therapies
Novel Targets in Drug Discovery
Clinical Research Outsourcing and India
Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success
Structure-Guided Drug Design: Rediscovering the Importance of Drug Structure for Drug Discovery
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities
ADME in Children and The Elderly: Clinical Challenges and Opportunities
|
 |
|
|